Recent news on Colesevelam

KineMed Evaluates The Mechanism Of Action For Colesevelam In ...  -  May 22, 2007
Medical News Today (press release),KineMed will apply its proprietary translational medicine technology, KineMarker(TM), to measure the effects of colesevelam HCl on multiple metabolic

Cholesterol-Lowering Drug Combined With Metformin Improves Glucose ...  -  Apr 16, 2007
DG NewsIn an earlier, smaller study of 65 patients with type 2 diabetes, HbA1c levels were reduced by 0.5% when colesevelam was added to an existing oral

Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to ...  -  Mar 29, 2007
Drug Newswire (press release),A study recently published in the November issue of Current Medical Research and Opinion showed that taking WelChol(R) (colesevelam HCI) in combination with

Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to ...  -  Mar 28, 2007
PR-Inside.com (Pressemitteilung),The, "Lipid Lowering Effects of Colesevelam HCI in Combination with Ezetimibe" (1) study was also presented in November at the American Heart Association's

Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012 ...  -  26 Mar 2007
PR Newswire (press release),Patient 1 Patient 2 Patient 3 80 mg atorvastatin + Concurrent 80 mg 10 mg ezetimibe + 40 mg rosuvastatin + therapies atorvastatin 625 mg colesevelam + 10 mg

Daiichi Sankyo, Inc. Announces Filing Of Supplemental New Drug ...  -  Jan 3, 2007
PipelineReview.com (press release),Announced today that it has filed a supplemental New Drug Application (sNDA) with the US Food and Drug Administration (FDA) for WelChol® (colesevelam HCl)

Daiichi Sankyo, Inc. Announces Filing Of Supplemental New Drug ...  -  Jan 3, 2007
Medical News Today (press release),...with the US Food and Drug Administration (FDA) for WelChol(R) (colesevelam HCl) to improve glycemic control in patients with type 2 diabetes mellitus.

Genzyme Reports Strong Fourth-Quarter Revenue Growth to Conclude ...  -  Jan 10, 2007
Oxfordshire Bioscience Network (press release),Other revenue-including oncology revenue, sales of pharmaceutical intermediates, R&D revenue, and royalties from the sale of WelChol® (colesevelam

FDA Asked to Approve Use of Cholesterol Drug WelChol as a Diabetes ...  -  Jan 4, 2007
Diabetes Drug Report,Daiichi Sankyo, Inc. announced it has asked the US Food and Drug Administration (FDA) to approve use of its cholesterol drug WelChol® (colesevelam HCl) as a

Daiichi Sankyo, Inc. Announces Filing of New Drug Application for ...  -  Nov 29, 2006
PipelineReview.com (press release),...the fastest growing angiotensin receptor blocker on the market, and WelChol(R) (colesevelam HCl), the number one branded bile acid sequestrant.

Genzyme Reports Strong Third-Quarter Financial Results  Oct 12, 2006
Other revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol® (colesevelam hydrochloride) -- was ... -Yahoo! News (press release) Genzyme Reports Strong Third-Quarter Financial Results  Oct 12, 2006
Other revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol(R) (colesevelam hydrochloride) -- was ... -Drug Newswire (press release), Rosuvastatin plus diet in hypercholesterolemic adults unable to ...  Aug 27, 2006
Eighteen patients subsequently failed to reach LDL-cholesterol goals with non-statin lipid-lowering therapies alone ( Colesevelam, 10 patients; Ezetimibe, 8 ... -Xagena.it

Colesevelam HCl and Ezetimibe Combination Therapy Provides ...  -  Nov 13, 2006
DG NewsThe study, entitled "Lipid Lowering Effects of Colesevelam HCl in Combination with Ezetimibe," aimed to evaluate whether the combination of WelChol plus

New Study Confirms WelChol Improves Glycemic Control In Patients ...  -  Nov 16, 2006
Medical News Today (press release),Poster presentation #1581, entitled "Colesevelam HCl Improves Glycemic Control in Type 2 Diabetes Mellitus Subjects Managed with Insulin Therapy,"

First Study To Evaluate WelChol/Ezetimibe And Simvastatin Effect ...  -  Nov 14, 2006
Medical News Today (press release),Data presented today at the American Heart Association's Scientific Sessions 2006 in Chicago showed that WelChol(R) (colesevelam HCl) plus ezetimibe and

First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect ...  -  Nov 13, 2006
Drug Newswire (press release),The poster presentation, entitled "Lipoprotein Particle Size, Concentration and Lipid Ratio Effects of Colesevelam HCl in Combination with Ezetimibe and

Daiichi Sankyo, Inc. Announces Filing of New Drug Application for ...  -  Nov 29, 2006
PipelineReview.com (press release),...the fastest growing angiotensin receptor blocker on the market, and WelChol(R) (colesevelam HCl), the number one branded bile acid sequestrant.

Rosuvastatin plus diet in hypercholesterolemic adults unable to ...  Aug 27, 2006
Eighteen patients subsequently failed to reach LDL-cholesterol goals with non-statin lipid-lowering therapies alone ( Colesevelam, 10 patients; Ezetimibe, 8 ... -Xagena.it

Study of Tolevamer for C. difficile-Associated Diarrhea Published ...  Aug 16, 2006
R) (sevelamer hydrochloride) controls serum phosphorus in patients with chronic kidney disease on dialysis, and WelChol(R) (colesevelam hydrochloride) reduces ... -DG News

Results of Phase 2 Study of Tolevamer for C. difficile-Associated ...  Aug 16, 2006
...sevelamer hydrochloride) controls serum phosphorus in patients with chronic kidney disease on dialysis, and WelChol® (colesevelam hydrochloride) reduces LDL ... -Oxfordshire Bioscience Network

Feeling squeezed by statins  Aug 8, 2006
...grapefruit. Ezetimibe (Zetia), colesevelam (WelChol) and niacin are other cholesterol-lowering options that work safely with grapefruit. ... -NorthJersey.com

1st Clinical Trial To Show Colesevelam HCl Plus Stable Oral ...  Jun 26, 2006
The first data to demonstrate the effect of WelChol® (colesevelam hydrochloride) on glucose lowering was presented today at The American Diabetes ... -Medical News Today

Delivers Solid Earnings Growth Based on Strong Top-Line ...  Jul 18, 2006
Other revenue-including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol® (colesevelam hydrochloride)-increased 30 ... -Oxfordshire Bioscience Network

Genzyme Reports Second-Quarter Financial Results  Jul 12, 2006
...revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol(R) (colesevelam hydrochloride) -- increased ... -Drug Newswire



Addition Of A Bile Acid Sequestrant (WelChol, Colesevelam HCl) To ...  Apr 19, 2006
Data published today in the April 15 issue of the American Journal of Cardiology demonstrated that adding WelChol(R) (colesevelam hydrochloride) to stable ... - Medical News Today

Genzyme Reports Financial Results for the First Quarter of 2006  Apr 19, 2006
Other revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol(R) (colesevelam hydrochloride) -- was ... - MSN Money





US Subsidiaries Join Together to Form Daiichi Sankyo, Inc.  Apr 3, 2006
...six products, including BENICAR(R) (olmesartan medoxomil), BENICAR(R) HCT (olmesartan medoxomil-hydrochlorothiazide), WelChol(R) (colesevelam HCl), FLOXIN(R ... - PR Newswire

US Subsidiaries Join Together to Form Daiichi Sankyo, Inc.  Apr 3, 2006
...supports six products, including BENICAR® (olmesartan medoxomil), BENICAR® HCT (olmesartan medoxomil-hydrochlorothiazide), WelChol® (colesevelam HCl), FLOXIN ... - Market Wire

Genzyme Reports 22 Percent Increase in Fourth-Quarter Revenue  Jan 9, 2006
...including oncology revenue, sales of pharmaceutical intermediates, R&D revenue, and royalties from the sale of WelChol(R) (colesevelam hydrochloride) -- was ... - MSN Money

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional